3001.20.00.00 - Extracts of glands or other organs or of their secretions 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 10% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3001.20.00.00, specifically covers extracts derived from glands or other organs of animals or humans, as well as their secretions. These extracts are intended for organotherapeutic uses, meaning they are prepared and utilized for their medicinal or remedial properties in treating diseases or conditions related to specific organs or bodily functions. This includes substances like insulin extracted from pancreatic glands or liver extracts.
The distinguishing feature of this category, 3001.20.00.00, from its sibling, 3001.90.01 (Other), lies in the nature of the product. While 3001.20.00.00 is strictly for *extracts*, 3001.90.01 is a residual category for other organotherapeutic substances not covered by specific subheadings within heading 3001, such as dried and powdered glands or heparin and its salts. Therefore, the presence of an extraction process to obtain the active therapeutic compound is key for classification under 3001.20.00.00.
As this is a leaf node, there are no further subcategories within 3001.20.00.00. Classification at this level hinges on confirming that the product is indeed an extract of glands, organs, or their secretions, and that its intended use is for organotherapeutic purposes. The source of the extract (human or animal) is generally not a deciding factor for this specific subheading, provided the organotherapeutic application is established.